MAPK3 and ovarian cancer: A study by Ye et al. observed decreased phosphorylation of epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase 1/2 (ERK1/2), protein kinase (AKT), and reduced migration and invasion of ovarian cancer cells on silencing the CTHRC1.